| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GDP phosphatase activity | 9.96e-05 | 12 | 157 | 3 | GO:0004382 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.42e-04 | 34 | 157 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.42e-04 | 71 | 157 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.91e-04 | 44 | 157 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone modifying activity | 4.68e-04 | 229 | 157 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 4.93e-04 | 20 | 157 | 3 | GO:0017110 | |
| GeneOntologyBiologicalProcess | AIM2 inflammasome complex assembly | 2.27e-07 | 8 | 158 | 4 | GO:0140970 | |
| GeneOntologyBiologicalProcess | positive regulation of AIM2 inflammasome complex assembly | 1.75e-06 | 4 | 158 | 3 | GO:0140973 | |
| GeneOntologyBiologicalProcess | regulation of AIM2 inflammasome complex assembly | 8.67e-06 | 6 | 158 | 3 | GO:0140971 | |
| GeneOntologyBiologicalProcess | cytolysis in another organism | 3.58e-05 | 9 | 158 | 3 | GO:0051715 | |
| GeneOntologyBiologicalProcess | positive regulation of pyroptotic inflammatory response | 3.58e-05 | 9 | 158 | 3 | GO:0140639 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 4.80e-05 | 218 | 158 | 9 | GO:0071897 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | PNKP FMR1 PDGFB RTF2 ING5 TSN STOX1 REV3L XRCC2 SSRP1 RRM1 STN1 NEK2 SETD2 PTPRC NAF1 PRPF19 DCLRE1A PRKDC FH DDX39B | 8.11e-05 | 1081 | 158 | 21 | GO:0006259 |
| GeneOntologyBiologicalProcess | cytolysis | 9.22e-05 | 12 | 158 | 3 | GO:0019835 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 9.48e-05 | 138 | 158 | 7 | GO:2000278 | |
| GeneOntologyCellularComponent | host intracellular region | 8.65e-06 | 6 | 160 | 3 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 8.65e-06 | 6 | 160 | 3 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 8.65e-06 | 6 | 160 | 3 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 8.65e-06 | 6 | 160 | 3 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 8.65e-06 | 6 | 160 | 3 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 8.65e-06 | 6 | 160 | 3 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 8.65e-06 | 6 | 160 | 3 | GO:0020005 | |
| GeneOntologyCellularComponent | symbiont cell surface | 2.40e-05 | 8 | 160 | 3 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 3.57e-05 | 9 | 160 | 3 | GO:0044217 | |
| GeneOntologyCellularComponent | host cellular component | 1.87e-04 | 15 | 160 | 3 | GO:0018995 | |
| GeneOntologyCellularComponent | dendritic filopodium | 3.46e-04 | 4 | 160 | 2 | GO:1902737 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.19e-03 | 7 | 160 | 2 | GO:0070776 | |
| MousePheno | abnormal bone marrow cell morphology/development | DLGAP2 ZNF493 SPI1 PDGFB MATK ING5 ZNF208 PICALM RGS18 DST PTPRC KMT2A PRKDC DIAPH3 HERC1 ZNF107 ARHGAP21 ABCC10 | 3.15e-05 | 706 | 120 | 18 | MP:0002398 |
| MousePheno | abnormal hematopoietic stem cell physiology | 3.98e-05 | 45 | 120 | 5 | MP:0010763 | |
| MousePheno | abnormal proerythroblast morphology | 4.06e-05 | 74 | 120 | 6 | MP:0002416 | |
| MousePheno | abnormal hematopoietic stem cell morphology | 4.96e-05 | 112 | 120 | 7 | MP:0004808 | |
| MousePheno | increased susceptibility to parasitic infection induced morbidity/mortality | 9.68e-05 | 11 | 120 | 3 | MP:0010750 | |
| Domain | Znf_C2H2-like | ZNF438 ZNF93 AKAP8 ZNF493 TSHZ2 ZNF273 ZNF429 ZNF208 ZNF217 ZNF236 ZFPM2 PRDM2 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF804B ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 2.00e-07 | 796 | 156 | 23 | IPR015880 |
| Domain | Znf_C2H2 | ZNF438 ZNF93 AKAP8 ZNF493 TSHZ2 ZNF273 ZNF429 ZNF208 ZNF217 ZNF236 ZFPM2 PRDM2 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF804B ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 2.44e-07 | 805 | 156 | 23 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF438 ZNF93 AKAP8 ZNF493 TSHZ2 ZNF273 ZNF429 ZNF208 ZNF217 ZNF236 ZFPM2 PRDM2 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF804B ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 2.60e-07 | 808 | 156 | 23 | SM00355 |
| Domain | zf-C2H2 | ZNF438 ZNF93 ZNF493 TSHZ2 ZNF273 ZNF429 ZNF208 ZNF217 ZNF236 ZFPM2 PRDM2 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 3.30e-07 | 693 | 156 | 21 | PF00096 |
| Domain | zf-C2H2_6 | ZNF93 ZNF493 ZNF273 ZNF429 ZNF208 ZNF236 PRDM2 ZNF676 ZNF728 ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 4.03e-07 | 314 | 156 | 14 | PF13912 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF438 ZNF93 ZNF493 TSHZ2 ZNF273 ZNF429 ZNF208 ZNF217 ZNF236 ZFPM2 PRDM2 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF804B ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 5.11e-07 | 775 | 156 | 22 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF438 ZNF93 ZNF493 TSHZ2 ZNF273 ZNF429 ZNF208 ZNF217 ZNF236 ZFPM2 PRDM2 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF804B ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 5.33e-07 | 777 | 156 | 22 | PS00028 |
| Domain | - | ZNF438 ZNF93 ZNF493 ZNF273 ZNF429 ZNF208 ZNF217 ZNF236 ZFPM2 PRDM2 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 1.00e-06 | 679 | 156 | 20 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF438 ZNF93 ZNF493 ZNF273 ZNF429 ZNF208 ZNF217 ZNF236 ZFPM2 PRDM2 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 1.40e-06 | 694 | 156 | 20 | IPR013087 |
| Domain | KRAB | ZNF93 ZNF273 ZNF429 ZNF208 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF737 ZNF506 ZNF431 ZNF782 | 1.00e-05 | 358 | 156 | 13 | PS50805 |
| Domain | KRAB | ZNF93 ZNF273 ZNF429 ZNF208 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF737 ZNF506 ZNF431 ZNF782 | 1.38e-05 | 369 | 156 | 13 | SM00349 |
| Domain | KRAB | ZNF93 ZNF273 ZNF429 ZNF208 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF737 ZNF506 ZNF431 ZNF782 | 1.42e-05 | 370 | 156 | 13 | IPR001909 |
| Domain | GBP_C | 6.57e-05 | 10 | 156 | 3 | PF02841 | |
| Domain | P-loop_NTPase | PNKP MYH11 GBP1 GBP2 GAL3ST4 GBP3 AK9 XRCC2 ATAD3B GTPBP8 GIMAP8 ATAD3C MTIF2 NAV1 MYH15 RAB21 DDX39A DDX39B ABCC10 | 8.66e-05 | 848 | 156 | 19 | IPR027417 |
| Domain | G_GB1_RHD3_dom | 8.98e-05 | 11 | 156 | 3 | IPR030386 | |
| Domain | Guanylate-bd_N | 8.98e-05 | 11 | 156 | 3 | IPR015894 | |
| Domain | Guanylate-bd_C | 8.98e-05 | 11 | 156 | 3 | IPR003191 | |
| Domain | GBP | 8.98e-05 | 11 | 156 | 3 | PF02263 | |
| Domain | G_GB1_RHD3 | 8.98e-05 | 11 | 156 | 3 | PS51715 | |
| Domain | DUF3523 | 2.07e-04 | 3 | 156 | 2 | IPR021911 | |
| Domain | DUF3523 | 2.07e-04 | 3 | 156 | 2 | PF12037 | |
| Domain | KRAB | ZNF93 ZNF273 ZNF429 ZNF208 ZNF708 ZNF37A ZNF728 ZNF737 ZNF506 ZNF431 ZNF782 | 2.15e-04 | 358 | 156 | 11 | PF01352 |
| Domain | SET | 3.73e-04 | 41 | 156 | 4 | PF00856 | |
| Domain | PHD | 4.11e-04 | 75 | 156 | 5 | PF00628 | |
| Domain | - | PNKP GBP1 GBP2 GBP3 AK9 XRCC2 ATAD3B GTPBP8 GIMAP8 ATAD3C MTIF2 NAV1 RAB21 DDX39A DDX39B ABCC10 | 5.20e-04 | 746 | 156 | 16 | 3.40.50.300 |
| Domain | Znf_PHD-finger | 5.22e-04 | 79 | 156 | 5 | IPR019787 | |
| Domain | SET | 5.82e-04 | 46 | 156 | 4 | SM00317 | |
| Domain | SET_dom | 8.00e-04 | 50 | 156 | 4 | IPR001214 | |
| Domain | SET | 8.00e-04 | 50 | 156 | 4 | PS50280 | |
| Domain | PHD | 9.00e-04 | 89 | 156 | 5 | SM00249 | |
| Domain | Znf_PHD | 9.95e-04 | 91 | 156 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.21e-03 | 95 | 156 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.26e-03 | 96 | 156 | 5 | PS01359 | |
| Pubmed | MYH11 INTS12 ANKRD30B STOX1 SSRP1 LCP1 NCAPH PTGFR PSME3IP1 NEK2 ATAD3B DST ATAD3C KIAA0825 SLC27A1 SCN9A PLXNA4 KMT2A PRPF19 MYH15 UGGT2 EIF3A PRKDC DIAPH3 RAB21 DDX39A DDX39B ARHGAP21 | 1.08e-10 | 1442 | 160 | 28 | 35575683 | |
| Pubmed | 3.75e-09 | 29 | 160 | 6 | 14563677 | ||
| Pubmed | 5.60e-09 | 15 | 160 | 5 | 15885501 | ||
| Pubmed | ZNF93 ZNF493 ZNF273 ZNF208 ZNF708 ZNF728 EHMT1 ZNF737 ZNF107 HBE1 | 1.32e-08 | 181 | 160 | 10 | 37372979 | |
| Pubmed | GTPase properties of the interferon-induced human guanylate-binding protein 2. | 9.56e-08 | 3 | 160 | 3 | 8706832 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 32620042 | ||
| Pubmed | [Guanylate-binding protein 2 regulates the maturation of mouse dendritic cells induced by β-glucan]. | 9.56e-08 | 3 | 160 | 3 | 29089068 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 1715024 | ||
| Pubmed | Two families of GTPases dominate the complex cellular response to IFN-gamma. | 9.56e-08 | 3 | 160 | 3 | 9862701 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 11726669 | ||
| Pubmed | GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis. | 9.56e-08 | 3 | 160 | 3 | 38636926 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 15717119 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 35383115 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 20950129 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 30062052 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 26416908 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 32354743 | ||
| Pubmed | Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. | 9.56e-08 | 3 | 160 | 3 | 23248289 | |
| Pubmed | Domain motions, dimerization, and membrane interactions of the murine guanylate binding protein 2. | 9.56e-08 | 3 | 160 | 3 | 36639389 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 16914101 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 22730319 | ||
| Pubmed | IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes. | 1.39e-07 | 11 | 160 | 4 | 27693356 | |
| Pubmed | 1.80e-07 | 239 | 160 | 10 | 26641092 | ||
| Pubmed | TPP2 DLGAP2 MYH11 FMR1 MAP2 WDR37 VIRMA ATAD3B DST NF1 ATAD3C SLC27A1 PLXNA4 NAV1 KMT2A PRPF19 TANC1 EIF3A FH PPP6R2 DDX39B ARHGAP21 NCK2 | 1.86e-07 | 1431 | 160 | 23 | 37142655 | |
| Pubmed | 2.07e-07 | 12 | 160 | 4 | 35906252 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 8917111 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 39337476 | ||
| Pubmed | Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. | 3.81e-07 | 4 | 160 | 3 | 7823961 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 36609599 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 10386861 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 38404575 | ||
| Pubmed | 5.66e-07 | 15 | 160 | 4 | 25774716 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | AKAP8 EML4 MATK ZNF217 SSRP1 VIRMA PRDM2 SETD2 NF1 PTPRC NAF1 KMT2A PLA2G4A UTP20 PRKDC KAT6B | 6.45e-07 | 774 | 160 | 16 | 15302935 |
| Pubmed | 7.52e-07 | 16 | 160 | 4 | 8467795 | ||
| Pubmed | Murine GBP-2: a new IFN-gamma-induced member of the GBP family of GTPases isolated from macrophages. | 9.49e-07 | 5 | 160 | 3 | 9858320 | |
| Pubmed | TCR Affinity Biases Th Cell Differentiation by Regulating CD25, Eef1e1, and Gbp2. | 9.49e-07 | 5 | 160 | 3 | 30858199 | |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 12396730 | ||
| Pubmed | Unique features of different members of the human guanylate-binding protein family. | 9.49e-07 | 5 | 160 | 3 | 17266443 | |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 21151871 | ||
| Pubmed | Essential Role of mGBP7 for Survival of Toxoplasma gondii Infection. | 9.49e-07 | 5 | 160 | 3 | 31964735 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPP2 USP34 MAP2 CALR GBP1 GBP2 TSN SSRP1 RRM1 NCAPH NAMPT DNAAF10 NAF1 PAK2 PLA2G4A PRPF19 EIF3A PRKDC HERC1 FH DDX39A DDX39B | 9.76e-07 | 1455 | 160 | 22 | 22863883 |
| Pubmed | 9.80e-07 | 17 | 160 | 4 | 25774715 | ||
| Pubmed | 1.26e-06 | 18 | 160 | 4 | 27001747 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 21757726 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 17293456 | ||
| Pubmed | FMR1 EML4 FREM2 IBTK NAMPT DST LLGL1 MTIF2 DDHD1 KMT2A UGGT2 TANC1 PPP6R2 ARHGAP21 | 2.08e-06 | 650 | 160 | 14 | 38777146 | |
| Pubmed | 2.43e-06 | 21 | 160 | 4 | 19158679 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 3.23e-06 | 135 | 160 | 7 | 31077711 | |
| Pubmed | TRIF signaling is required for caspase-11-dependent immune responses and lethality in sepsis. | 3.30e-06 | 7 | 160 | 3 | 30587103 | |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 21502320 | ||
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 20505078 | ||
| Pubmed | 4.73e-06 | 202 | 160 | 8 | 24639526 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | FMR1 EML4 RTF2 LCP1 WDR37 PICALM ATAD3B PTPRC ATAD3C NAF1 EIF3A DDX39A DDX39B ATG16L2 | 4.95e-06 | 701 | 160 | 14 | 30196744 |
| Pubmed | In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. | 5.26e-06 | 8 | 160 | 3 | 16689661 | |
| Pubmed | 6.68e-06 | 57 | 160 | 5 | 18022353 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NCAPH PICALM PSME3IP1 IBTK SETD2 NAMPT DST NAF1 PAK2 KMT2A PRPF19 EIF3A PRKDC PRMT7 PPP6R2 ARHGAP21 | 7.13e-06 | 934 | 160 | 16 | 33916271 |
| Pubmed | Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. | 7.87e-06 | 9 | 160 | 3 | 24739961 | |
| Pubmed | Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. | 7.87e-06 | 9 | 160 | 3 | 33479228 | |
| Pubmed | SLC37A1 PNKP FMR1 AKAP8 CALR EML4 NCAPH PICALM NF1 PTPRC PARP16 GLE1 SLC27A1 PRPF19 CHID1 EIF3A PRKDC DDX39A | 7.92e-06 | 1168 | 160 | 18 | 19946888 | |
| Pubmed | Functional analysis of the SRY-KRAB interaction in mouse sex determination. | 1.12e-05 | 10 | 160 | 3 | 18588511 | |
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 1.12e-05 | 10 | 160 | 3 | 28334111 | |
| Pubmed | FMR1 EML4 RRM1 PSME3IP1 NAMPT DST LLGL1 TANC1 PRMT7 DDX39B ARHGAP21 | 1.30e-05 | 472 | 160 | 11 | 38943005 | |
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 1.53e-05 | 11 | 160 | 3 | 24715728 | |
| Pubmed | Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. | 1.53e-05 | 11 | 160 | 3 | 15469996 | |
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 24337748 | ||
| Pubmed | Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. | 1.53e-05 | 11 | 160 | 3 | 18025219 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | VWA3A CNBD1 TTLL3 INTS12 CYBC1 WDR37 NCAPH VIRMA CASP12 ATAD3B NF1 ATAD3C GLE1 DDHD1 HERC1 PRMT7 RAB21 ATG16L2 | 1.80e-05 | 1242 | 160 | 18 | 30973865 |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 29459437 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16949217 | ||
| Pubmed | Dimerization and its role in GMP formation by human guanylate binding proteins. | 2.10e-05 | 2 | 160 | 2 | 20923658 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12461747 | ||
| Pubmed | SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. | 2.10e-05 | 2 | 160 | 2 | 29249820 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20610707 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 38225262 | ||
| Pubmed | MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. | 2.10e-05 | 2 | 160 | 2 | 29777171 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28498454 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23086406 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20483731 | ||
| Pubmed | Parsing the roles of DExD-box proteins DDX39A and DDX39B in alternative RNA splicing. | 2.10e-05 | 2 | 160 | 2 | 38801080 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23325844 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 38377942 | ||
| Pubmed | The interferon-inducible GBP1 gene: structure and mapping to human chromosome 1. | 2.10e-05 | 2 | 160 | 2 | 7518790 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 36460216 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20573985 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21135032 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TPP2 AKAP8 RTF2 SSRP1 NCAPH VIRMA NAMPT EHMT1 UTP20 PRKDC RAB21 DDX39A DDX39B | 2.48e-05 | 704 | 160 | 13 | 29955894 |
| Pubmed | 2.64e-05 | 13 | 160 | 3 | 19850934 | ||
| Pubmed | 3.35e-05 | 14 | 160 | 3 | 34111398 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 INTS12 EML4 TSN BROX SETD2 FAT1 NF1 MROH1 UGGT2 PRKDC HERC1 FH RAB21 DDX39B ABCC10 | 3.37e-05 | 1061 | 160 | 16 | 33845483 |
| Pubmed | WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy. | 3.46e-05 | 40 | 160 | 4 | 29078390 | |
| Pubmed | USP34 AKAP8 ZDBF2 IBTK SETD2 GLE1 DDHD1 NAV1 UGGT2 DCLRE1A TANC1 RAB21 NCK2 | 3.75e-05 | 733 | 160 | 13 | 34672954 | |
| Pubmed | 4.17e-05 | 15 | 160 | 3 | 17114464 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | INTS12 AKAP8 MAP2 MATK SSRP1 VIRMA C6orf132 DST NF1 NAV1 KMT2A TANC1 RAB21 ARHGAP21 | 4.80e-05 | 861 | 160 | 14 | 36931259 |
| Pubmed | ZNF93 AK9 SSRP1 RRM1 ZNF236 NCAPH ATAD3B GTPBP8 ZNF506 ZNF107 | 4.91e-05 | 451 | 160 | 10 | 36168627 | |
| Pubmed | 5.12e-05 | 16 | 160 | 3 | 14743444 | ||
| Pubmed | TPP2 USP34 FMR1 CALR LCP1 VIRMA DST NF1 KMT2A UTP20 PRKDC FH | 5.36e-05 | 653 | 160 | 12 | 22586326 | |
| Pubmed | 5.49e-05 | 209 | 160 | 7 | 36779422 | ||
| Pubmed | USP34 FMR1 AKAP8 ING5 REV3L SSRP1 WDR37 SETD2 ATAD3B FAT1 CCNB3 MTIF2 NAF1 EHMT1 TANC1 KAT6B | 6.13e-05 | 1116 | 160 | 16 | 31753913 | |
| Pubmed | Utility of Peripherin Versus MAP-2 and Calretinin in the Evaluation of Hirschsprung Disease. | 6.29e-05 | 3 | 160 | 2 | 26469323 | |
| Pubmed | Identification of functional cooperative mutations of SETD2 in human acute leukemia. | 6.29e-05 | 3 | 160 | 2 | 24509477 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | ZNF93 ZNF493 ZNF429 ZNF208 ZNF708 ZNF676 ZNF728 ZNF737 ZNF431 ZNF723 | 1.96e-11 | 122 | 160 | 10 | chr19p12 |
| Cytoband | 19p12 | ZNF93 ZNF493 ZNF208 ZNF708 ZNF676 ZNF728 ZNF737 ZNF431 ZNF723 | 3.35e-11 | 90 | 160 | 9 | 19p12 |
| Cytoband | 1p22.2 | 1.28e-04 | 28 | 160 | 3 | 1p22.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF438 ZNF93 ZNF493 TSHZ2 ZNF273 ZNF429 ZNF208 ZNF217 ZNF236 ZFPM2 ZNF708 ZNF23 ZNF676 ZNF37A ZNF728 ZNF737 ZNF506 ZNF431 ZNF782 ZNF107 | 4.05e-09 | 718 | 104 | 20 | 28 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.20e-05 | 34 | 104 | 4 | 487 | |
| GeneFamily | PHD finger proteins | 1.71e-04 | 90 | 104 | 5 | 88 | |
| GeneFamily | WD repeat domain containing | 7.97e-04 | 262 | 104 | 7 | 362 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | TPP2 USP34 INTS12 MAP2 MTF2 CAPN6 GBP1 GBP2 GBP3 RRM1 LCP1 PTGFR FABP1 EIF3A SUCO SPESP1 | 1.31e-05 | 741 | 160 | 16 | MM1037 |
| Coexpression | KONDO_COLON_CANCER_HCP_WITH_H3K27ME1 | 1.80e-05 | 26 | 160 | 4 | M13354 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 MTF2 REV3L WDR37 PICALM IBTK SETD2 FAT1 NAMPT DST MTIF2 UTP20 EIF3A KAT6B RAB21 SUCO NPAT | 2.04e-05 | 856 | 160 | 17 | M4500 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | TPP2 USP34 INTS12 MAP2 CAPN6 GBP1 GBP2 GBP3 RRM1 LCP1 PTGFR VIRMA FABP1 EIF3A SUCO | 2.26e-05 | 689 | 160 | 15 | MM1041 |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | ZNF493 ZNF273 XRCC2 NEK2 SETD2 HASPIN NAV1 PRPF19 UGGT2 ZNF107 PPP6R2 DDX39B | 2.41e-05 | 454 | 160 | 12 | M19927 |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN | 3.19e-05 | 199 | 160 | 8 | M5242 | |
| Coexpression | GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN | 3.31e-05 | 200 | 160 | 8 | M8218 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP | 3.31e-05 | 200 | 160 | 8 | M8491 | |
| Coexpression | MIKKELSEN_NPC_LCP_WITH_H3K4ME3 | 3.89e-05 | 62 | 160 | 5 | MM865 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 FMR1 EML4 MATK CYBC1 GBP2 GBP3 ZNF217 REV3L LCP1 PICALM STN1 PRDM2 SETD2 PTPRC GIMAP8 ERAP2 PAK2 KMT2A HERC1 KAT6B RAB21 NPAT | 3.93e-05 | 1492 | 160 | 23 | M40023 |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN | ZNF438 PNKP ZNF493 GBP1 GBP2 GBP3 ZNF208 CASP12 CHID1 ZNF107 NCK2 | 3.97e-05 | 403 | 160 | 11 | MM1029 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | TPP2 USP34 DLGAP2 SPI1 MTF2 ZNF273 XRCC2 RRM1 LCP1 PRDM2 PTPRC ZNF37A GLE1 PAK2 PRPF19 MYH15 PRKDC DDX39A AIM2 DDX39B ABCC10 NPAT | 4.16e-05 | 1394 | 160 | 22 | M9585 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | TPP2 USP34 INTS12 MAP2 MTF2 CAPN6 GBP2 RRM1 LCP1 PTGFR FABP1 EIF3A SUCO SPESP1 | 9.05e-05 | 690 | 160 | 14 | M12224 |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | TPP2 USP34 INTS12 MAP2 CAPN6 GBP1 GBP2 GBP3 RRM1 LCP1 PTGFR FABP1 EIF3A SUCO | 9.62e-05 | 694 | 160 | 14 | MM1039 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | FMR1 MTF2 ZNF273 RRM1 NCAPH BROX NEK2 SETD2 ZNF23 ERAP2 C8orf76 ZNF506 PRKDC DIAPH3 FH SUCO | 9.80e-05 | 877 | 160 | 16 | M2241 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 9.97e-05 | 300 | 160 | 9 | M8702 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | TPP2 USP34 INTS12 MAP2 CAPN6 GBP2 RRM1 LCP1 PTGFR VIRMA FABP1 EIF3A SUCO | 1.23e-04 | 623 | 160 | 13 | M15896 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 1.14e-06 | 143 | 156 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.45e-06 | 97 | 156 | 7 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 9.97e-06 | 19 | 156 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.52e-05 | 21 | 156 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | MYH11 MAP2 MUC16 GBP1 GBP2 REV3L WDR37 F8 PCDH20 ZFPM2 ZNF23 DST HMCN1 PLXNA4 PLA2G4A KAT6B ARHGAP21 | 7.46e-05 | 791 | 156 | 17 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.63e-05 | 191 | 156 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 9.64e-05 | 100 | 156 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 9.72e-05 | 33 | 156 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | MYH11 MAP2 TSHZ2 MUC16 GBP2 ZFPM2 FREM2 HMCN1 PLXNA4 PLA2G4A AIM2 | 9.95e-05 | 372 | 156 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | MYH11 MAP2 CAPN6 MUC16 GBP2 ZFPM2 FREM2 HMCN1 PLXNA4 PLA2G4A AIM2 | 1.34e-04 | 385 | 156 | 11 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 1.70e-04 | 158 | 156 | 7 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.52e-09 | 196 | 160 | 10 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.52e-09 | 196 | 160 | 10 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.81e-08 | 188 | 160 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.20e-08 | 197 | 160 | 9 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-07 | 171 | 160 | 8 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-07 | 171 | 160 | 8 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.92e-07 | 197 | 160 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.79e-06 | 170 | 160 | 7 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-06 | 170 | 160 | 7 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.51e-06 | 176 | 160 | 7 | 98176bf3c961d5262593e2d5d002836adb010e13 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-06 | 177 | 160 | 7 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.22e-06 | 181 | 160 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.53e-06 | 183 | 160 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 4.87e-06 | 185 | 160 | 7 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 4.87e-06 | 185 | 160 | 7 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 5.60e-06 | 189 | 160 | 7 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.60e-06 | 189 | 160 | 7 | 78dcda09109a5cfb04ba069f16ec80987b3ad432 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.80e-06 | 190 | 160 | 7 | e0b363f772817cfc6ab425430805c1cddcba23f0 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.00e-06 | 191 | 160 | 7 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.00e-06 | 191 | 160 | 7 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.00e-06 | 191 | 160 | 7 | 47156e5f1d790707f42f6283104a44b33af613e5 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.00e-06 | 191 | 160 | 7 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 6.00e-06 | 191 | 160 | 7 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.00e-06 | 191 | 160 | 7 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.43e-06 | 193 | 160 | 7 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.43e-06 | 193 | 160 | 7 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.65e-06 | 194 | 160 | 7 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.65e-06 | 194 | 160 | 7 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | Monocytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 6.65e-06 | 194 | 160 | 7 | fa6a2794baa6be6298f415330ff51b26a5402571 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.65e-06 | 194 | 160 | 7 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.65e-06 | 194 | 160 | 7 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.65e-06 | 194 | 160 | 7 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.65e-06 | 194 | 160 | 7 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.35e-06 | 197 | 160 | 7 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | hematopoetic_progenitors-CD34+_MPP|hematopoetic_progenitors / Lineage and Cell class | 7.85e-06 | 199 | 160 | 7 | ec127c5a374a005ecf1377fb9bd245a7244505bf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.85e-06 | 199 | 160 | 7 | 9da8b48ec1c1c105fcbab6ae8f08166e7d5e8a35 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | e4be88bcef2738915f711b32c95e9c613e7edf96 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-NoSEP / Disease, condition lineage and cell class | 8.11e-06 | 200 | 160 | 7 | f70cc9198339eab7fbc68f5d9b75dfb28c9afc89 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.11e-06 | 200 | 160 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 8.11e-06 | 200 | 160 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-NoSEP / Disease, Lineage and Cell Type | 8.11e-06 | 200 | 160 | 7 | d86119766b9c4f1570cd8045313345f9be46d431 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-05 | 151 | 160 | 6 | b85a763459a0f019d1f9975d09b9f2247d62c9d3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 160 | 160 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 160 | 160 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 162 | 160 | 6 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.66e-05 | 162 | 160 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 167 | 160 | 6 | d72b08b3cbc34b30a11dcf512e472b64d1606ec1 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 167 | 160 | 6 | 22f7384ff2044898d7b0b01cb9d9a3cbaa93a9a3 | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.49e-05 | 170 | 160 | 6 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 4.24e-05 | 176 | 160 | 6 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.37e-05 | 177 | 160 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-05 | 178 | 160 | 6 | aa9f68a66e292f331faef881bbd0d028f0f2b0c5 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 178 | 160 | 6 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.66e-05 | 179 | 160 | 6 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 179 | 160 | 6 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.66e-05 | 179 | 160 | 6 | db76edd368eeca05a2a5d407c3eb2f535ade0ce3 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.80e-05 | 180 | 160 | 6 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.84e-05 | 110 | 160 | 5 | 854f21560ce7cb5e1923403b6d04df3d804431e2 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Platelet|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.95e-05 | 181 | 160 | 6 | 724efbc200e8388829bc7d81830c2689a95fa838 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-05 | 181 | 160 | 6 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.95e-05 | 181 | 160 | 6 | 1fa882ee66e6f835acf3f293fd24dc7f8b1eff99 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.11e-05 | 182 | 160 | 6 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.11e-05 | 182 | 160 | 6 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-05 | 183 | 160 | 6 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.26e-05 | 183 | 160 | 6 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-05 | 183 | 160 | 6 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.43e-05 | 184 | 160 | 6 | 4c7d05f1a4556b13cedbaaf88d67ac32d09b109b | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.43e-05 | 184 | 160 | 6 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 184 | 160 | 6 | d7f348aa8901d819c68da20728b9238407bcdca9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.43e-05 | 184 | 160 | 6 | 3e9d75af578297950e469f23fb2d28393a2feef8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 185 | 160 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 6.29e-05 | 189 | 160 | 6 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.29e-05 | 189 | 160 | 6 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.48e-05 | 190 | 160 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.67e-05 | 191 | 160 | 6 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-05 | 191 | 160 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-05 | 191 | 160 | 6 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 6.67e-05 | 191 | 160 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-05 | 191 | 160 | 6 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.67e-05 | 191 | 160 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-05 | 191 | 160 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 6.67e-05 | 191 | 160 | 6 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.67e-05 | 191 | 160 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 6.67e-05 | 191 | 160 | 6 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.67e-05 | 191 | 160 | 6 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.67e-05 | 191 | 160 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.67e-05 | 191 | 160 | 6 | 56b45259dfc38bd5ea43b0e3adf47e7e2c043a5d | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 6.67e-05 | 191 | 160 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Neutrophil|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.87e-05 | 192 | 160 | 6 | 545c3990cbe3c04bfd95a0ab7499d2c4af509be1 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.87e-05 | 192 | 160 | 6 | 5417f024fcc89eaeab33f4a2c6421d1cfabd681b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.87e-05 | 192 | 160 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | moderate-Myeloid-Neutrophil|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.87e-05 | 192 | 160 | 6 | 8105408400dac5dcb0ce62b558433257559c9f09 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.07e-05 | 193 | 160 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.07e-05 | 193 | 160 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.27e-05 | 194 | 160 | 6 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.27e-05 | 194 | 160 | 6 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| Disease | Leukemia, Myelocytic, Acute | 3.63e-05 | 173 | 154 | 7 | C0023467 | |
| Disease | memory performance | 6.13e-05 | 409 | 154 | 10 | EFO_0004874 | |
| Disease | neuromuscular disease (implicated_via_orthology) | 1.61e-04 | 4 | 154 | 2 | DOID:440 (implicated_via_orthology) | |
| Disease | viral infectious disease (implicated_via_orthology) | 2.68e-04 | 5 | 154 | 2 | DOID:934 (implicated_via_orthology) | |
| Disease | Acute myelomonocytic leukemia | 2.68e-04 | 5 | 154 | 2 | C0023479 | |
| Disease | urate measurement, bone density | DLGAP2 TSHZ2 NXPH1 GBP3 LCP1 PLXNA4 NAV1 UGGT2 VWA3B PRKDC KAT6B | 4.27e-04 | 619 | 154 | 11 | EFO_0003923, EFO_0004531 |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 5.10e-04 | 30 | 154 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | Acute Myeloid Leukemia, M1 | 5.14e-04 | 125 | 154 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 5.14e-04 | 125 | 154 | 5 | C1879321 | |
| Disease | blood barium measurement | 7.41e-04 | 34 | 154 | 3 | EFO_0021528 | |
| Disease | triacylglycerol 58:10 measurement | 7.41e-04 | 34 | 154 | 3 | EFO_0010437 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 7.42e-04 | 8 | 154 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | myelofibrosis (is_implicated_in) | 7.42e-04 | 8 | 154 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | late-onset Alzheimers disease | 8.91e-04 | 292 | 154 | 7 | EFO_1001870 | |
| Disease | mean platelet volume | MYH11 SPI1 ING5 IRAK1BP1 ZNF217 XRCC2 LCP1 PICALM ZFPM2 SETD2 PTPRC DDHD1 DDX39B NCK2 | 9.49e-04 | 1020 | 154 | 14 | EFO_0004584 |
| Disease | Thrombocytosis, Autosomal Dominant | 9.51e-04 | 9 | 154 | 2 | C3489628 | |
| Disease | Uterine leiomyoma | 1.34e-03 | 91 | 154 | 4 | HP_0000131 | |
| Disease | Proteinuria | 1.48e-03 | 43 | 154 | 3 | C0033687 | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 1.68e-03 | 45 | 154 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.73e-03 | 12 | 154 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Thrombocythemia, Essential | 1.73e-03 | 12 | 154 | 2 | C0040028 | |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | epithelial cell adhesion molecule measurement | 2.42e-03 | 51 | 154 | 3 | EFO_0010574 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 2.58e-03 | 352 | 154 | 7 | EFO_0007014 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.70e-03 | 53 | 154 | 3 | C1961099 | |
| Disease | leukemia | 3.00e-03 | 55 | 154 | 3 | C0023418 | |
| Disease | Dyskeratosis Congenita | 3.10e-03 | 16 | 154 | 2 | C0265965 | |
| Disease | cleft lip | 3.86e-03 | 284 | 154 | 6 | EFO_0003959 | |
| Disease | Colorectal Carcinoma | 3.91e-03 | 702 | 154 | 10 | C0009402 | |
| Disease | syndrome (implicated_via_orthology) | 3.92e-03 | 18 | 154 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | parahippocampal gyrus volume measurement | 3.92e-03 | 18 | 154 | 2 | EFO_0010318 | |
| Disease | Myeloid Leukemia | 3.92e-03 | 18 | 154 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.92e-03 | 18 | 154 | 2 | C0023466 | |
| Disease | Malignant neoplasm of breast | ZNF438 AKAP8 XRCC2 PCDH20 SETD2 NF1 LLGL1 PTPRC ELAPOR1 EHMT1 PLA2G4A UTP20 KAT6B | 4.25e-03 | 1074 | 154 | 13 | C0006142 |
| Disease | Severe Combined Immunodeficiency | 4.83e-03 | 20 | 154 | 2 | C0085110 | |
| Disease | blood lead measurement | 5.02e-03 | 66 | 154 | 3 | EFO_0007040 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKTFIKSSLQVSHEK | 6 | Q8N944 | |
| ETLSGHKDKVTAAKF | 416 | Q8NAA4 | |
| KATHQKEFDTLSGKL | 746 | Q9BXX2 | |
| AAEQFKKTSLHVAKS | 511 | O43823 | |
| AKKDVKGSYVSIHSS | 31 | Q13838 | |
| KKDIKGSYVSIHSSG | 31 | O00148 | |
| LTSGVHSTIKVIKAK | 326 | O14862 | |
| QKLFTKSHSLEGSSK | 236 | Q9P1A6 | |
| IAGSKLKEIFDKIHS | 436 | Q53GS7 | |
| SLKTVSSGAKKSFEL | 501 | O76090 | |
| KDTKSADQKTTLLHF | 871 | Q9NSV4 | |
| TKAHVEKDFIAFKSS | 256 | Q6UXS9 | |
| QLSLKKKSTSHGKVF | 746 | Q8WWL7 | |
| TSLTKLSLQDGHKAK | 26 | Q9Y483 | |
| DKHITTLQASFLTKK | 46 | Q9UL25 | |
| ALGFLHSKSKDSAEK | 16 | Q96CB8 | |
| ELSSTAKSKAHFFGK | 576 | Q8WYB5 | |
| VSAKTKFKLTAHEGC | 841 | Q15334 | |
| DTVKLKINFHGSKSS | 556 | Q14207 | |
| SSDKTIKSFFPHSGK | 196 | Q96K31 | |
| SVSSTGGKLIAHKKL | 3591 | Q14517 | |
| STEKSAVLHKLTTGA | 6671 | Q8WXI7 | |
| GTSLETFISHLEVKK | 611 | Q5T3U5 | |
| KLFSKIGGSVLESHK | 381 | Q8N6Y1 | |
| VIGTKTKSFDVHKSV | 76 | Q9H511 | |
| QKIKSATIHAASKVF | 231 | Q5VVH5 | |
| TAPEALKHGKFTSKS | 391 | P42679 | |
| VVKTSKSSSKHRGAV | 306 | Q8IV33 | |
| PSSVIKKKVHFSGES | 376 | P51955 | |
| SVSLKASGKNKHFKV | 321 | O43639 | |
| ASILATFSVTEGKKK | 626 | P46199 | |
| VKAHGKKVLTSFGDA | 61 | P02100 | |
| EKKSVTSHSSGDHVK | 1211 | Q9P2D0 | |
| TSHSSGDHVKKVSFK | 1216 | Q9P2D0 | |
| IKDHKDFSKTLTAQS | 4886 | Q03001 | |
| TSKKSLFGKIKSFTS | 976 | Q6UXG2 | |
| SFVIKLTDGKHSVEK | 1276 | Q5SZK8 | |
| GHDKDFSTQTKKLST | 641 | Q8WW38 | |
| SIKKVSSSKGSDGHT | 456 | Q15751 | |
| KSTTLKLADFGLAKH | 491 | Q9C098 | |
| PTKGFASVSEKAHKS | 246 | Q96MX6 | |
| GVTKPIFHSTKITSK | 136 | P43088 | |
| FKHTHDKTALKETLG | 226 | P01127 | |
| KIFHGLKSTDVAKTF | 76 | P13796 | |
| KNHSLAFVGTKSGKL | 441 | Q9HCM2 | |
| KKKGFSLGSTVQSHT | 61 | P32455 | |
| KKNGFSLGSTVKSHT | 61 | P32456 | |
| KNKGFSLGSTVKSHT | 61 | Q9H0R5 | |
| GSLAKEKTQTLHKFI | 201 | P00451 | |
| HFSTKVLGIKVETKD | 771 | Q8NDA8 | |
| FLKTHKSGSSSVLSL | 71 | Q96RP7 | |
| YVIVLTKIDKSSKGH | 221 | Q8N3Z3 | |
| KKGELISTSSAKFSA | 1016 | Q96RW7 | |
| KITSFKISVKHARSG | 226 | Q9UMZ3 | |
| SSKVLTIHSAGKAEF | 91 | Q8N5Y8 | |
| KSSEQILATLKGHTK | 251 | Q9UMS4 | |
| ILATLKGHTKKVTSV | 256 | Q9UMS4 | |
| HKIISIFSGTEKGSK | 51 | Q13177 | |
| GTKKEDSTAKIHAVT | 266 | Q5TID7 | |
| TVQGTFSKLFGKKHT | 6 | Q5T0Z8 | |
| FSKLFGKKHTTTPST | 11 | Q5T0Z8 | |
| TTAVSADLGTHKSLK | 441 | P57057 | |
| AHKDFKKAVGAFSVT | 146 | Q06787 | |
| KAVEDIHGLFSLSKK | 251 | Q14152 | |
| GFSDKIKVINKHSTE | 111 | Q9NVM4 | |
| KKFTITSSVTGKKHT | 601 | Q68DX3 | |
| GKKHTFVTDSAKTSK | 611 | Q68DX3 | |
| IAKTAHKNGSTLKET | 471 | P07954 | |
| LSLAIAKHKQSSFTK | 16 | Q9NPH9 | |
| LGKHVFKSKFSDQTV | 31 | Q8ND71 | |
| FDKSTGKVVLKTFSL | 71 | Q9BQA9 | |
| KHKSDFGKFVLSSGK | 41 | P27797 | |
| TGKTLFAKKLALHSG | 181 | Q5T2N8 | |
| SFLKTTGSDFSLKKE | 241 | Q6P1S2 | |
| KKHKGGSEFTDTILS | 156 | Q8WYH8 | |
| ASFSFHKKKIVTDVS | 386 | Q8TF76 | |
| TTAHFSSKDKLQEVK | 901 | Q6P179 | |
| TFKEKHSSKSFLEPG | 2436 | Q03164 | |
| SKSLSKPEVKHQVFS | 1226 | Q9ULL0 | |
| EDHVASVKKSVSSKG | 56 | Q9HC35 | |
| LSKVKVFTKSAHGGL | 666 | Q6PJP8 | |
| KSIDGKDAVHSFKLS | 331 | Q8NEL9 | |
| CFHSKVFGKDTKISI | 151 | Q96HH9 | |
| AKVKQGHISFKVISS | 621 | Q9Y6Q1 | |
| FKSITHSTVGSKGEK | 316 | Q9H9B1 | |
| AKATVKELASLHGTK | 331 | P15086 | |
| PVHTTLSKSDAKKAA | 16 | Q9BWS9 | |
| KDKFISLVLKHIGTS | 146 | O75170 | |
| AGLTSKKSKLESHSD | 766 | Q13029 | |
| FLSNKKTSTLKHLLG | 21 | Q96KF2 | |
| KSKKIHVVDSGLTFN | 541 | P47712 | |
| SKTLSKSEHSLFQAK | 136 | Q8NEY1 | |
| AEKALGKAASHIKSI | 71 | Q9BY42 | |
| TVAKKITSEYGLKHL | 1426 | Q5TCS8 | |
| LHLSLKTSKIKSSGE | 2091 | O75691 | |
| KDTTSKAIHSIFKNA | 256 | Q9H668 | |
| ASSFKGKTKIFEHII | 526 | Q8N0V4 | |
| ELLKSGSSKSTLKHI | 31 | P58417 | |
| SALTKSFSGKKGHVS | 211 | Q06033 | |
| KKGASFQTVASLHKE | 651 | Q9Y2K3 | |
| KLLAGAVKHKSSESG | 151 | Q9GZU8 | |
| KDKISGFGSSVDKHL | 1056 | Q15858 | |
| IFKGLSKKTGISSSH | 871 | Q9C0D5 | |
| SIASKGSKFKELVTH | 66 | Q6UW49 | |
| DLLHTVFKNGKVTKS | 456 | P43490 | |
| AGKSTFLKKHLVSAG | 376 | Q96T60 | |
| KGTFQFSSKHKEALA | 196 | P17947 | |
| KHFKFTITAGSKVIQ | 46 | P07148 | |
| KSDHPGISITDLSKK | 566 | Q08945 | |
| SLKIAAGIFKHLKES | 146 | Q5VW32 | |
| TGKTLFAKKLALHSG | 356 | Q5T9A4 | |
| NDKHLKTLSKTVFSE | 171 | Q8NA66 | |
| THNESVSALVDKFKK | 331 | Q15003 | |
| AVVASSHKGKKDTSI | 196 | P35749 | |
| GKTFSFKSVLTVHQK | 361 | P17032 | |
| HLASLEGKKIKDSTA | 281 | Q13492 | |
| HTGGTIKKTKICSEF | 91 | Q9BQY6 | |
| GKAFKQSSTLTTHKI | 266 | Q8TF32 | |
| GKAFNQSSTLTKHKK | 291 | P35789 | |
| GKAFVASSTLSKHEI | 431 | P35789 | |
| KAFNLSSTLTAHKKI | 671 | Q9UII5 | |
| GKVFSVFSVLTKHKI | 296 | Q14593 | |
| GKAFSVFSTLTKHKI | 436 | Q14593 | |
| RTGVSFTFSKKVHLK | 216 | A4D1E1 | |
| FTFSKKVHLKLESSA | 221 | A4D1E1 | |
| KVHLKLESSASVFSE | 226 | A4D1E1 | |
| GKAFSKVSTLNTHKA | 371 | Q8N7Q3 | |
| FFKLIHGSGKEETSK | 21 | Q9NS28 | |
| SKLSVKPSIFHKDAA | 551 | O60673 | |
| IAVSNLHKETKKVFS | 81 | P23921 | |
| ATSKKIAHSVFSKGD | 471 | Q6PCB7 | |
| TISKGHKIQKTSDLK | 506 | Q6ZVD7 | |
| GKGFSQSSTLTKHKI | 431 | P0DPD5 | |
| KAFSKASTLTAHKTI | 291 | P0DKX0 | |
| KAFTTFSSLTKHKVI | 431 | P0DKX0 | |
| HSFALLGKKKSSNLT | 926 | P29144 | |
| KSQGKTLSAGLKFHE | 276 | Q9HCK1 | |
| LAHKDTKVSIKVGST | 1746 | P21359 | |
| HSKLVGTKALSTTGK | 596 | Q9Y4R7 | |
| SHGKGKITKSEFESK | 206 | Q9UBS9 | |
| VTGHFLKVTSSASKK | 401 | Q9NRE2 | |
| KSSEFLKHAGKETIV | 916 | Q9BYW2 | |
| TKKIDLSHVTSKCGS | 1696 | P11137 | |
| SFKDTSTGHKNKEFV | 3541 | P78527 | |
| KSNSLKKHFFIIGES | 261 | O43543 | |
| GKAFSIFSILTKHKV | 426 | P17019 | |
| ELSKGQLKTKASHST | 101 | Q9Y2I8 | |
| ADLFHSIATQKKKVG | 81 | P62068 | |
| GKAFSKVSTLTTHKA | 291 | O43345 | |
| GKSFSTFSILTKHKV | 531 | O43345 | |
| GKAFSKFSILTKHKV | 671 | O43345 | |
| GKTFSKVSTLTTHKA | 811 | O43345 | |
| GKAFSTFSILTKHKV | 1231 | O43345 | |
| KSHEKYLIALKSSGL | 291 | Q6ZT12 | |
| GKTFSISSTFTKHKI | 291 | Q86V71 | |
| GKTFSVFSILTKHKI | 311 | Q6ZR52 | |
| GKSFSVFSTLTKHKI | 451 | Q6ZR52 | |
| GKSFTVKSTLDCHVK | 1201 | Q9UL36 | |
| KVHTKKTAFGTSSAQ | 236 | O75362 | |
| SKIKKIVHSIVSSFA | 61 | Q6XPS3 | |
| KTLTGGKSFSQKSHI | 286 | Q6ZMW2 | |
| GKSISFDTKLVKHEI | 146 | P17027 | |
| KLSTSFVLETFIHSK | 2306 | Q70CQ2 | |
| GTIAFLKDLSAKTHS | 276 | Q502W6 | |
| DSIKSFTVSLHKENK | 1211 | Q9NYU1 | |
| EDAKLSFKHVSSLKG | 891 | Q5T5U3 | |
| SFKHVSSLKGIKIAD | 896 | Q5T5U3 | |
| HKFTNASKIIKTDFG | 376 | P08575 | |
| LGKHKHETFITSSGK | 1591 | Q69YN4 | |
| LSGKAHFVSKITSSK | 236 | Q7Z4V0 | |
| GKAFISSSTLTKHEI | 291 | Q5JVG8 | |
| SKIHSLLTKGFINEK | 1121 | A6NCI4 | |
| GTVKTHLTSLKTKFP | 66 | Q15631 | |
| GKAFKRSSILTAHKI | 291 | O75373 | |
| FNSSDHIESKGIKIK | 256 | Q96HR8 |